Scientists have created an ‘early signs timeline’ for Alzheimer’s disease that they believe could help experts detect the condition up to 25 years before it strikes.
The study, published in the New England Journal of Medicine, looked at 128 people with a family history of early Alzheimer’s.
The pharmaceutical industry has beat a concerted retreat from developing drugs for diseases that affect the brain, stymied by the lengthy development times for these agents and a string of failures. Despite the evident risks, a new study shows how industry leaders should perhaps be taking the long view.